NO20092729L - Lipasevarianter for farmasoytisk anvendelse - Google Patents
Lipasevarianter for farmasoytisk anvendelseInfo
- Publication number
- NO20092729L NO20092729L NO20092729A NO20092729A NO20092729L NO 20092729 L NO20092729 L NO 20092729L NO 20092729 A NO20092729 A NO 20092729A NO 20092729 A NO20092729 A NO 20092729A NO 20092729 L NO20092729 L NO 20092729L
- Authority
- NO
- Norway
- Prior art keywords
- lipases
- digestive
- improved
- pharmaceutical use
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87119606P | 2006-12-21 | 2006-12-21 | |
PCT/US2007/087168 WO2008079685A2 (fr) | 2006-12-21 | 2007-12-12 | Variantes lipasiques pour une utilisation pharmaceutique |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092729L true NO20092729L (no) | 2009-09-18 |
Family
ID=38043020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092729A NO20092729L (no) | 2006-12-21 | 2009-07-20 | Lipasevarianter for farmasoytisk anvendelse |
Country Status (16)
Country | Link |
---|---|
US (3) | US8273348B2 (fr) |
EP (6) | EP2455462B1 (fr) |
JP (1) | JP5406040B2 (fr) |
KR (1) | KR20090101930A (fr) |
CN (2) | CN105112386A (fr) |
AR (1) | AR064494A1 (fr) |
AU (1) | AU2007337150A1 (fr) |
BR (1) | BRPI0721103A2 (fr) |
CA (3) | CA2961041C (fr) |
IL (1) | IL198893A0 (fr) |
MX (1) | MX2009006597A (fr) |
NO (1) | NO20092729L (fr) |
RU (1) | RU2009128067A (fr) |
TW (1) | TW200829698A (fr) |
WO (1) | WO2008079685A2 (fr) |
ZA (1) | ZA200903598B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2314646T3 (es) | 2004-03-22 | 2009-03-16 | Solvay Pharmaceuticals Gmbh | Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos. |
RU2413532C2 (ru) | 2005-07-29 | 2011-03-10 | Зольвай Фармасьютиклз Гмбх | Способ получения стерилизованного порошкообразного панкреатина |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
CN105112386A (zh) | 2006-12-21 | 2015-12-02 | 诺维信公司 | 用于药物用途的脂肪酶变体 |
MX2010009457A (es) * | 2008-02-29 | 2010-09-24 | Procter & Gamble | Composicion detergente que comprende lipasa. |
CN102016015B (zh) | 2008-02-29 | 2014-09-03 | 帝斯曼知识产权资产管理有限公司 | 对短链脂肪酸具有高度特异性的脂肪酶及其用途 |
JP2011514805A (ja) * | 2008-02-29 | 2011-05-12 | ノボザイムス アクティーゼルスカブ | 向上した安定性を有する脂肪分解酵素変異体、及びこれをコードするポリヌクレオチド |
DK2734633T3 (da) | 2011-07-22 | 2019-06-11 | Novozymes North America Inc | Fremgangsmåder til forbehandling af celluloseholdigt materiale og forbedring af hydrolyse deraf |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
EP2798053B1 (fr) | 2011-12-29 | 2018-05-16 | Novozymes A/S | Compositions de détergent avec variants de lipases |
ES2794644T3 (es) * | 2012-02-03 | 2020-11-18 | Novozymes As | Variantes de lipasa y polinucleótidos que las codifican |
US9909109B2 (en) | 2012-04-02 | 2018-03-06 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2014059360A1 (fr) * | 2012-10-12 | 2014-04-17 | Danisco Us Inc. | Compositions comprenant un variant d'enzyme lipolytique et procédés associés |
MY192746A (en) * | 2013-05-14 | 2022-09-06 | Novozymes As | Detergent compositions |
MX371497B (es) * | 2013-07-19 | 2020-01-31 | Danisco Us Inc | Composiciones y metodos que comprenden una variante de enzima lipolitica. |
US10287562B2 (en) * | 2014-11-20 | 2019-05-14 | Novoszymes A/S | Alicyclobacillus variants and polynucleotides encoding same |
EP4067485A3 (fr) * | 2014-12-05 | 2023-01-04 | Novozymes A/S | Variantes de la lipase et polynucléotides les codant |
US11268076B2 (en) | 2014-12-09 | 2022-03-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
CN107864658A (zh) | 2015-04-07 | 2018-03-30 | 诺维信公司 | 用于选择具有脂肪酶活性的酶的方法 |
WO2017005640A1 (fr) * | 2015-07-03 | 2017-01-12 | Novozymes A/S | Compositions détergentes présentant une stabilité accrue en présence de sulfites |
US11028131B2 (en) * | 2017-01-30 | 2021-06-08 | Nippon Medical School Foundation | Mutant of adeno-associated virus (AAV) capsid protein |
US11286443B2 (en) * | 2017-09-27 | 2022-03-29 | The Procter & Gamble Company | Detergent compositions comprising lipases |
CA3073362A1 (fr) * | 2017-09-27 | 2019-04-04 | Novozymes A/S | Variants de lipase et compositions de microcapsules comprenant de tels variants de lipase |
EP3749760A1 (fr) * | 2018-02-08 | 2020-12-16 | Novozymes A/S | Variants de lipase et compositions en comprenant |
CN111334369B (zh) * | 2020-03-11 | 2022-10-21 | 陕西科技大学 | 一种酶法制备卵磷脂型pufa的方法 |
EP4237552A2 (fr) * | 2020-10-29 | 2023-09-06 | Novozymes A/S | Variants de lipase et compositions comprenant de tels variants de lipase |
CN113846074B (zh) * | 2021-10-20 | 2022-10-21 | 南京林业大学 | 一种疏棉状嗜热丝孢菌脂肪酶突变体g91c及其应用 |
WO2023225459A2 (fr) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions et procédés de prévention, de traitement, de suppression et/ou d'élimination d'infestations et d'infections phytopathogènes |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK173590D0 (da) * | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
US5869438A (en) | 1990-09-13 | 1999-02-09 | Novo Nordisk A/S | Lipase variants |
DE69129988T2 (de) * | 1990-09-13 | 1999-03-18 | Novo Nordisk As | Lipase-varianten |
DK46693D0 (fr) * | 1993-04-23 | 1993-04-23 | Novo Nordisk As | |
DE69130113T2 (de) | 1990-12-05 | 1999-05-12 | Novo Nordisk As | Proteine mit geänderten epitopen und verfahren zur deren herstellung |
US5914306A (en) | 1991-05-01 | 1999-06-22 | Novo Nordisk A/S | Stabilized enzymes |
DK39693D0 (da) | 1993-04-02 | 1993-04-02 | Novo Nordisk As | Enzym |
AU7807394A (en) | 1993-10-04 | 1995-05-01 | Novo Nordisk A/S | An enzyme preparation comprising a modified enzyme |
AU1806795A (en) | 1994-02-22 | 1995-09-04 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
AU3924095A (en) | 1994-11-24 | 1996-06-17 | Novo Nordisk A/S | A process for producing polypeptides with reduced allergenicity |
WO1996017929A1 (fr) | 1994-12-07 | 1996-06-13 | Novo Nordisk A/S | Polypeptide a allergenicite reduite |
CN1165614C (zh) | 1995-01-26 | 2004-09-08 | 诺沃奇梅兹有限公司 | 含有木聚糖酶的动物饲料添加剂 |
JP4307549B2 (ja) | 1995-07-14 | 2009-08-05 | ノボザイムス アクティーゼルスカブ | 脂肪分解活性を有する修飾された酵素 |
US6495357B1 (en) | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
ES2221934T3 (es) | 1995-08-11 | 2005-01-16 | Novozymes A/S | Nuevas enzimas lipoliticas. |
EP0954572A1 (fr) | 1997-01-10 | 1999-11-10 | Novo Nordisk A/S | Enzyme couplee a des molecules polymeres pour les soins de la peau |
JP2001511162A (ja) | 1997-02-06 | 2001-08-07 | ノボ ノルディスク アクティーゼルスカブ | 付加され、そして/又は除去された付着基を有するポリペプチド−ポリマー結合体 |
CA2294567A1 (fr) | 1997-06-25 | 1999-01-07 | Novo Nordisk A/S | Polypeptide modifie |
AU3247699A (en) | 1998-02-17 | 1999-09-06 | Novo Nordisk A/S | Lipase variant |
ATE328070T1 (de) * | 1998-02-17 | 2006-06-15 | Novozymes As | Lipasevariante |
JP2002527059A (ja) | 1998-10-13 | 2002-08-27 | ノボザイムス アクティーゼルスカブ | 低められた免疫応答を有する修飾されたポリペプチド |
NZ511291A (en) | 1998-10-30 | 2003-08-29 | Novozymes As | A method for selecting a protein variant that has reduced immunogenicity as compared with the parent or wild-type protein |
DE69936351T2 (de) | 1998-10-30 | 2008-02-21 | Novozymes A/S | Glykosylierte proteine mit reduzierter allergenität |
US7312062B2 (en) * | 1998-11-27 | 2007-12-25 | Novozymes A/S | Lipolytic enzyme variants |
EP1131416B1 (fr) | 1998-11-27 | 2009-09-02 | Novozymes A/S | Variants d'enzyme lipolytique |
CZ20013345A3 (cs) * | 1999-03-17 | 2002-01-16 | Solvay Pharmaceuticals Gmbh | Léčivo k léčení diabetu |
AU3420100A (en) | 1999-03-31 | 2000-10-23 | Novozymes A/S | Lipase variant |
CA2366843A1 (fr) * | 1999-03-31 | 2000-10-12 | Jesper Vind | Variante genetique de lipase |
CA2395343C (fr) | 2000-02-08 | 2009-06-30 | F. Hoffmann-La Roche Ag | Utilisation de proteases a acidite stable dans l'alimentation animale |
AU2001254622A1 (en) * | 2000-04-28 | 2001-11-12 | Novozymes A/S | Laccase mutants |
AU2002219020B2 (en) | 2001-01-10 | 2007-05-24 | Novozymes A/S | Thermostable lipolytic enzyme variant |
AR032392A1 (es) | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
JP4287149B2 (ja) | 2001-02-07 | 2009-07-01 | ノボザイムス アクティーゼルスカブ | リパーゼ変異体 |
US20050255544A1 (en) * | 2002-01-16 | 2005-11-17 | Novozymes A/S | Lipolytic enzyme variants and method for their production |
JP2007506405A (ja) | 2003-02-06 | 2007-03-22 | ノボザイムス アクティーゼルスカブ | 糸状菌におけるヒトh鎖抗体の発現 |
DK2270140T3 (en) | 2003-05-09 | 2016-03-14 | Novozymes As | Lipolytic enzyme variants |
EP1639102A2 (fr) | 2003-06-19 | 2006-03-29 | Novozymes A/S | Variantes genetiques de la phospholipase |
EP1639107B1 (fr) | 2003-06-19 | 2013-08-14 | Novozymes A/S | Proteases ameliorees et procedes de production de ces dernieres |
EP1711529A1 (fr) | 2004-01-21 | 2006-10-18 | Novozymes A/S | Production d'un anticorps monoclonal dans un champignon heterocaryon ou dans une cellule hote fongique |
ES2314646T3 (es) | 2004-03-22 | 2009-03-16 | Solvay Pharmaceuticals Gmbh | Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos. |
EP1809320B1 (fr) | 2004-10-14 | 2010-07-21 | Altus Pharmaceuticals Inc. | Compositions contenant de la lipase, de la protease et de l'amylase pour le traitement de l'insuffisance pancreatique |
US20080138856A1 (en) | 2005-02-10 | 2008-06-12 | Novozymes A/S | Enzymatic Enantioselective Ester or Amide Hydrolysis or Synthesis |
AU2006261442A1 (en) * | 2005-06-24 | 2006-12-28 | Novozymes A/S | Lipases for pharmaceutical use |
BRPI0611932A2 (pt) | 2005-06-24 | 2011-01-04 | Novozymes As | amilase, uso da mesma, composição farmacêutica, e, método para o tratamento de uma doença |
CA2612806A1 (fr) | 2005-06-24 | 2006-12-28 | Solvay Pharmaceuticals Gmbh | Proteases a usage pharmaceutique |
WO2007080197A2 (fr) * | 2006-01-16 | 2007-07-19 | Novozymes A/S | Enzymes immobilisees |
EP1979456A2 (fr) | 2006-01-23 | 2008-10-15 | The Procter & Gamble Company | Composition comprenant une lipase et un catalyseur de blanchiment |
EP1979477B1 (fr) * | 2006-01-23 | 2017-04-19 | Novozymes A/S | Variantes de lipase |
CN105112386A (zh) * | 2006-12-21 | 2015-12-02 | 诺维信公司 | 用于药物用途的脂肪酶变体 |
-
2007
- 2007-12-12 CN CN201510504893.8A patent/CN105112386A/zh active Pending
- 2007-12-12 EP EP12155319.2A patent/EP2455462B1/fr active Active
- 2007-12-12 CA CA2961041A patent/CA2961041C/fr active Active
- 2007-12-12 CA CA3081308A patent/CA3081308C/fr active Active
- 2007-12-12 EP EP12155315A patent/EP2455460A3/fr not_active Withdrawn
- 2007-12-12 EP EP07869130A patent/EP2099907A2/fr not_active Withdrawn
- 2007-12-12 EP EP10172609.9A patent/EP2261328B1/fr active Active
- 2007-12-12 WO PCT/US2007/087168 patent/WO2008079685A2/fr active Application Filing
- 2007-12-12 MX MX2009006597A patent/MX2009006597A/es not_active Application Discontinuation
- 2007-12-12 RU RU2009128067/10A patent/RU2009128067A/ru not_active Application Discontinuation
- 2007-12-12 CA CA2670643A patent/CA2670643C/fr active Active
- 2007-12-12 JP JP2009543078A patent/JP5406040B2/ja active Active
- 2007-12-12 KR KR1020097014850A patent/KR20090101930A/ko not_active Application Discontinuation
- 2007-12-12 EP EP12155294.7A patent/EP2455459B1/fr active Active
- 2007-12-12 CN CN200780051638.6A patent/CN101743308B/zh active Active
- 2007-12-12 US US12/519,868 patent/US8273348B2/en active Active
- 2007-12-12 EP EP12155317.6A patent/EP2455461B1/fr active Active
- 2007-12-12 AU AU2007337150A patent/AU2007337150A1/en not_active Abandoned
- 2007-12-12 BR BRPI0721103-1A patent/BRPI0721103A2/pt not_active IP Right Cessation
- 2007-12-18 TW TW096148377A patent/TW200829698A/zh unknown
- 2007-12-21 AR ARP070105859A patent/AR064494A1/es not_active Application Discontinuation
-
2009
- 2009-05-21 IL IL198893A patent/IL198893A0/en unknown
- 2009-05-25 ZA ZA200903598A patent/ZA200903598B/xx unknown
- 2009-07-20 NO NO20092729A patent/NO20092729L/no not_active Application Discontinuation
-
2012
- 2012-08-16 US US13/587,043 patent/US9029115B2/en active Active
-
2015
- 2015-04-06 US US14/679,563 patent/US9539311B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092729L (no) | Lipasevarianter for farmasoytisk anvendelse | |
NO20080437L (no) | Lipaser til farmasoytisk anvendelse | |
McClellan et al. | Cellular functions and molecular mechanisms of non-lysine ubiquitination | |
Draganov | Lactonases with oragnophosphatase activity: structural and evolutionary perspectives | |
Cornaciu et al. | The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively | |
DK1755656T3 (da) | Enzymer til farmaceutisk anvendelse | |
NO20080439L (no) | Amylaser til farmasoytisk anvendelse | |
Chandrasekaran et al. | In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity | |
JP2010512795A5 (fr) | ||
NO20080438L (no) | Proteaser til farmasoytisk anvendelse | |
RU2011102781A (ru) | ПРИМЕНЕНИЕ Hsp70 В КАЧЕСТВЕ РЕГУЛЯТОРА ФЕРМЕНТАТИВНОЙ АКТИВНОСТИ | |
DK1162995T3 (da) | Enzymer til behandling af diabetes mellitus type I | |
WO2009091994A3 (fr) | Fabrication d'enzymes de sulfatase lysosomales humaines hautement phosphorylées actives et leurs utilisations | |
EP4241854A3 (fr) | Enzyme des maladies lysosomales | |
EA201070187A1 (ru) | Модифицированные ферменты лецитин-холестерин ацилтрансферазы | |
MX2010005690A (es) | Variantes de proteasa para uso farmaceutico. | |
US11584920B2 (en) | Use of enzymes with a wide pH activity range as medicaments for promoting digestion | |
Mandrich et al. | Hyperthermophilic phosphotriesterases/lactonases for the environment and human health | |
Kohli et al. | Medical aspects of esterases: a mini review | |
Taylor et al. | Cholinesterase confabs and cousins: approaching forty years | |
TH88730A (th) | ไลเปสสำหรับการใช้ทางเภสัชกรรม | |
TH105721B (th) | แวเรียนท์ของไลเปสสำหรับการใช้ทางเภสัชกรรม | |
TH105721A (th) | แวเรียนท์ของไลเปสสำหรับการใช้ทางเภสัชกรรม | |
WO2008040739A3 (fr) | Variants d'enzymes lipolytiques | |
Roy et al. | Expression of recombinant human cathepsin K is enhanced by codon optimization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |